Relationships between apparent diffusion coefficient (ADC) histogram analysis parameters and PD-L 1-expression in head and neck squamous cell carcinomas: a preliminary study
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
McDermott JD, Bowles DW. Epidemiology of head and neck squamous cell carcinomas: impact on staging and prevention strategies. Curr Treat Options Oncol 2019; 20: 43. doi: 10.1007/s11864-019-0650-5McDermottJDBowlesDWEpidemiology of head and neck squamous cell carcinomas: impact on staging and prevention strategiesCurr Treat Options Oncol2019204310.1007/s11864-019-0650-5Open DOISearch in Google Scholar
Widmann G, Henninger B, Kremser C, Jaschke W. MRI sequences in head & neck radiology - state of the art. Rofo 2017; 189: 413-22. doi: 10.1055/s-0043-103280WidmannGHenningerBKremserCJaschkeWMRI sequences in head & neck radiology - state of the artRofo20171894132210.1055/s-0043-103280Open DOISearch in Google Scholar
Padhani AR, Liu G, Koh DM, Chenevert TL, Thoeny HC, Takahara T, et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 2009; 11: 102-25. doi: 10.1593/neo.81328PadhaniARLiuGKohDMChenevertTLThoenyHCTakaharaTet alDiffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendationsNeoplasia2009111022510.1593/neo.81328Open DOISearch in Google Scholar
Surov A, Meyer HJ, Wienke A. Can imaging parameters provide information regarding histopathology in head and neck squamous cell carcinoma? A meta-analysis. Transl Oncol 2018; 11: 498-503. doi: 10.1016/j.tranon.2018.02.004SurovAMeyerHJWienkeACan imaging parameters provide information regarding histopathology in head and neck squamous cell carcinoma? A meta-analysisTransl Oncol20181149850310.1016/j.tranon.2018.02.004Open DOISearch in Google Scholar
Surov A, Meyer HJ, Wienke A. Correlation between apparent diffusion coefficient (ADC) and cellularity is different in several tumors: a meta-analysis. Oncotarget 2017; 8: 59492-9. doi: 10.18632/oncotarget.17752SurovAMeyerHJWienkeACorrelation between apparent diffusion coefficient (ADC) and cellularity is different in several tumors: a meta-analysisOncotarget2017859492910.18632/oncotarget.17752Open DOISearch in Google Scholar
Hauge A, Wegner CS, Gaustad JV, Simonsen TG, Andersen LMK, Rofstad EK. Diffusion-weighted MRI-derived ADC values reflect collagen I content in PDX models of uterine cervical cancer. Oncotarget 2017; 8: 105682-91. doi: 10.18632/oncotarget.22388HaugeAWegnerCSGaustadJVSimonsenTGAndersenLMKRofstadEKDiffusion-weighted MRI-derived ADC values reflect collagen I content in PDX models of uterine cervical cancerOncotarget201781056829110.18632/oncotarget.22388Open DOISearch in Google Scholar
Swartz JE, Driessen JP, van Kempen PMW, de Bree R, Janssen LM, Pameijer FA, et al. Influence of tumor and microenvironment characteristics on diffusion-weighted imaging in oropharyngeal carcinoma: a pilot study. Oral Oncol 2018; 77: 9-15. doi: 10.1016/j.oraloncology.2017.12.001SwartzJEDriessenJPvan KempenPMWde BreeRJanssenLMPameijerFAet alInfluence of tumor and microenvironment characteristics on diffusion-weighted imaging in oropharyngeal carcinoma: a pilot studyOral Oncol20187791510.1016/j.oraloncology.2017.12.001Open DOISearch in Google Scholar
Meyer HJ, Leifels L, Hamerla G, Höhn AK, Surov A. ADC-histogram analysis in head and neck squamous cell carcinoma. Associations with different histopathological features including expression of EGFR, VEGF, HIF-1α, Her 2 and p53. A preliminary study. Magn Reson Imaging 2018; 54: 214-7. doi: 10.1016/j.mri.2018.07.013MeyerHJLeifelsLHamerlaGHöhnAKSurovAADC-histogram analysis in head and neck squamous cell carcinomaAssociations with different histopathological features including expression of EGFR, VEGF, HIF-1α, Her 2 and p53. A preliminary study. Magn Reson Imaging201854214710.1016/j.mri.2018.07.013Open DOISearch in Google Scholar
Surov A. Meyer HJ, Winter K, Richter C, Hoehn AK. Histogram analysis parameters of apparent diffusion coefficient reflect tumor cellularity and proliferation activity in head and neck squamous cell carcinoma. Oncotarget 2018; 9: 23599-607. doi: 10.18632/oncotarget.25284SurovAMeyerHJWinterKRichterCHoehnAKHistogram analysis parameters of apparent diffusion coefficient reflect tumor cellularity and proliferation activity in head and neck squamous cell carcinoma. Oncotarget201892359960710.18632/oncotarget.25284Open DOISearch in Google Scholar
Driessen JP, van Kempen PM, van der Heijden GJ, Philippens ME, Pameijer FA, Stegeman I, et al. Diffusion-weighted imaging in head and neck squamous cell carcinomas: a systematic review. Head Neck 2015; 37: 440-8. doi: 10.1002/hed.23575DriessenJPvan KempenPMvan derHeijden GJPhilippensMEPameijerFAStegemanIet alDiffusion-weighted imaging in head and neck squamous cell carcinomas: a systematic reviewHead Neck201537440810.1002/hed.23575Open DOISearch in Google Scholar
Koontz NA, Wiggins RH 3rd. Differentiation of benign and malignant head and neck lesions with diffusion tensor imaging and DWI. AJR Am J Roentgenol 2017; 208: 1110-5. doi: 10.2214/AJR.16.16486KoontzNAWigginsRH3rdDifferentiation of benign and malignant head and neck lesions with diffusion tensor imaging and DWIAJR Am J Roentgenol20172081110510.2214/AJR.16.16486Open DOISearch in Google Scholar
Surov A. Meyer HJ, Wienke A. Apparent diffusion coefficient for distinguishing between malignant and benign lesions in the head and neck region: a systematic review and meta-analysis. Front Oncol 2020; 9: 1362. doi: 10.3389/fonc.2019.01362SurovAMeyerHJWienkeAApparent diffusion coefficient for distinguishing between malignant and benign lesions in the head and neck region: a systematic review and meta-analysisFront Oncol20209136210.3389/fonc.2019.01362Open DOISearch in Google Scholar
King AD, Chow KK, Yu KH, Mo FK, Yeung DK, Yuan J, et al. Head and neck squamous cell carcinoma: diagnostic performance of diffusion-weighted MR imaging for the prediction of treatment response. Radiology 2013; 266: 531-8. doi: 10.1148/radiol.12120167KingADChowKKYuKHMoFKYeungDKYuanJet alHead and neck squamous cell carcinoma: diagnostic performance of diffusion-weighted MR imaging for the prediction of treatment responseRadiology2013266531810.1148/radiol.12120167Open DOISearch in Google Scholar
Law BK, King AD, Bhatia KS, Ahuja AT, Kam MK, Ma BB, et al. Diffusion-weighted imaging of nasopharyngeal carcinoma: can pretreatment DWI predict local failure based on long-term outcome? AJNR Am J Neuroradiol 2016; 37: 1706-12. doi: 10.3174/ajnr.A4792.LawBKKingADBhatiaKSAhujaATKamMKMaBBet alDiffusion-weighted imaging of nasopharyngeal carcinoma: can pretreatment DWI predict local failure based on long-term outcome?AJNR Am J Neuroradiol20163717061210.3174/ajnr.A4792Open DOISearch in Google Scholar
Matoba M, Tuji H, Shimode Y, Toyoda I, Kuginuki Y, Miwa K, et al. Fractional change in apparent diffusion coefficient as an imaging biomarker for predicting treatment response in head and neck cancer treated with chemoradiotherapy. AJNR Am J Neuroradiol 2014; 35: 379-85. doi: 10.3174/ajnr.A3706MatobaMTujiHShimodeYToyodaIKuginukiYMiwaKet alFractional change in apparent diffusion coefficient as an imaging biomarker for predicting treatment response in head and neck cancer treated with chemoradiotherapyAJNR Am J Neuroradiol2014353798510.3174/ajnr.A3706Open DOISearch in Google Scholar
Schneider S, Kadletz L, Wiebringhaus R, Kenner L, Selzer E, Füreder T, et al. PD-1 and PD-L1 expression in HNSCC primary cancer and related lymph node metastasis - impact on clinical outcome. Histopathology 2018; 73: 573-84. doi: 10.1111/his.13646SchneiderSKadletzLWiebringhausRKennerLSelzerEFürederTet alPD-1 and PD-L1 expression in HNSCC primary cancer and related lymph node metastasis - impact on clinical outcomeHistopathology2018735738410.1111/his.13646Open DOISearch in Google Scholar
Leemans CR, Snijders PJF, Brakenhoff RH. The molecular landscape of head and neck cancer. Nat Rev Cancer 2018; 18: 269-82. doi: 10.1038/nrc.2018.11LeemansCRSnijdersPJFBrakenhoffRHThe molecular landscape of head and neck cancerNat Rev Cancer2018182698210.1038/nrc.2018.11Open DOISearch in Google Scholar
Tang H, Zhou X, Ye Y, Zhou Y, Wu C, Xu Y. The different role of PD-L1 in head and neck squamous cell carcinomas: a meta-analysis. Pathol Res Pract 2020; 216: 152768. doi: 10.1016/j.prp.2019.152768TangHZhouXYeYZhouYWuCXuYThe different role of PD-L1 in head and neck squamous cell carcinomas: a meta-analysisPathol Res Pract202021615276810.1016/j.prp.2019.152768Open DOISearch in Google Scholar
Yang WF, Wong MCM, Thomson PJ, Li KY, Su YX. The prognostic role of PD-L1 expression for survival in head and neck squamous cell carcinoma: a systematic review and meta-analysis. Oral Oncol 2018; 86: 81-90. doi: 10.1016/j.oraloncology.2018.09.016YangWFWongMCMThomsonPJLiKYSuYXThe prognostic role of PD-L1 expression for survival in head and neck squamous cell carcinoma: a systematic review and meta-analysisOral Oncol201886819010.1016/j.oraloncology.2018.09.016Open DOISearch in Google Scholar
Lin YM, Sung WW, Hsieh MJ,Tsai SC, Lai HW, Yang SM, et al. High PD-L1 expression correlates with metastasis and poor prognosis in oral squamous cell carcinoma. PLoS One 2015; 10: e0142656. doi: 10.1371/journal.pone.0142656.LinYMSungWWHsiehMJTsaiSCLaiHWYangSMet alHigh PD-L1 expression correlates with metastasis and poor prognosis in oral squamous cell carcinomaPLoS One201510e014265610.1371/journal.pone.0142656Open DOISearch in Google Scholar
Surov A, Meyer HJ, Wienke A. Associations between apparent diffusion coefficient (ADC) and KI 67 in different tumors: a meta-analysis. Part 1: ADCmean.Oncotarget 2017; 8: 75434-44. doi: 10.18632/oncotarget.20406SurovAMeyerHJWienkeAAssociations between apparent diffusion coefficient (ADC) and KI 67 in different tumors: a meta-analysisPart 1: ADCmean. Oncotarget20178754344410.18632/oncotarget.20406Open DOISearch in Google Scholar
Just N. Improving tumour heterogeneity MRI assessment with histograms. Br J Cancer 2014; 111: 2205-13. doi: 10.1038/bjc.2014.512JustNImproving tumour heterogeneity MRI assessment with histogramsBr J Cancer201411122051310.1038/bjc.2014.512Open DOISearch in Google Scholar
de Perrot T, Lenoir V, Domingo Ayllón M, Dulguerov N, Pusztaszeri M, Becker M. Apparent diffusion coefficient histograms of human papillomavirus-positive and human papillomavirus-negative head and neck squamous cell carcinoma: assessment of tumor heterogeneity and comparison with histopathology. AJNR Am J Neuroradiol 2017; 38: 2153-60. doi: 10.3174/ajnr.A5370.dePerrot TLenoirVDomingoAyllón MDulguerovNPusztaszeriMBeckerMApparent diffusion coefficient histograms of human papillomavirus-positive and human papillomavirus-negative head and neck squamous cell carcinoma: assessment of tumor heterogeneity and comparison with histopathologyAJNR Am J Neuroradiol20173821536010.3174/ajnr.A5370Open DOISearch in Google Scholar
Rasmussen JH, Olin A, Lelkaitis G, Hansen AE, Andersen FL, Johannesen HH, et al. Does multiparametric imaging with 18F-FDG-PET/MRI capture spatial variation in immunohistochemical cancer biomarkers in head and neck squamous cell carcinoma? Br J Cancer 2020; 123: 46-53. doi: 10.1038/s41416-020-0876-9RasmussenJHOlinALelkaitisGHansenAEAndersenFLJohannesenHHet alDoes multiparametric imaging with 18F-FDG-PET/MRI capture spatial variation in immunohistochemical cancer biomarkers in head and neck squamous cell carcinoma?Br J Cancer2020123465310.1038/s41416-020-0876-9Open DOISearch in Google Scholar
Choi JW, Lee D, Hyun SH, Han M, Kim JH, Lee SJ. Intratumoural heterogeneity measured using FDG PET and MRI is associated with tumour-stroma ratio and clinical outcome in head and neck squamous cell carcinoma. Clin Radiol 2017; 72: 482-9. doi: 10.1016/j.crad.2017.01.019ChoiJWLeeDHyunSHHanMKimJHLeeSJIntratumoural heterogeneity measured using FDG PET and MRI is associated with tumour-stroma ratio and clinical outcome in head and neck squamous cell carcinomaClin Radiol201772482910.1016/j.crad.2017.01.019Open DOISearch in Google Scholar
Chow LQM, Haddad R, Gupta S, Mahipal A, Mehra R, Tahara M, et al. Antitumor activity of pembrolizumab in biomarker-unselected patients with recurrent and/or metastatic head and neck squamous cell carcinoma: results from the phase Ib KEYNOTE-012 expansion cohort. J Clin Oncol 2016; 34: 3838-45. doi: 10.1200/JCO.2016.68.1478.ChowLQMHaddadRGuptaSMahipalAMehraRTaharaMet alAntitumor activity of pembrolizumab in biomarker-unselected patients with recurrent and/or metastatic head and neck squamous cell carcinoma: results from the phase Ib KEYNOTE-012 expansion cohortJ Clin Oncol20163438384510.1200/JCO.2016.68.1478Open DOISearch in Google Scholar
Ferris RL, Blumenschein G Jr, Fayette J, Guigay J, Colevas AD, Licitra L, et al. Nivolumab for recurrent squamous-cell carcinoma of the head and neck. N Engl J Med 2016; 375: 1856-67. doi: 10.1056/NEJMoa1602252FerrisRLBlumenscheinG JrFayetteJGuigayJColevasADLicitraLet alNivolumab for recurrent squamous-cell carcinoma of the head and neckN Engl J Med201637518566710.1056/NEJMoa1602252Open DOISearch in Google Scholar
Seiwert TY, Burtness B, Mehra R, Weiss J, Berger R, Eder JP, et al. Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial. Lancet Oncol 2016; 17: 956-65. doi: 10.1016/S1470-2045(16)30066-3SeiwertTYBurtnessBMehraRWeissJBergerREderJPet alSafety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trialLancet Oncol2016179566510.1016/S1470-2045(16)30066-3Open DOISearch in Google Scholar
Ledgerwood LG, Kumar D, Eterovic AK, Wick J, Chen K, Zhao H, et al. The degree of intratumor mutational heterogeneity varies by primary tumor sub-site. Oncotarget 2016; 7: 27185-98. doi: 10.18632/oncotarget.8448.LedgerwoodLGKumarDEterovicAKWickJChenKZhaoHet alThe degree of intratumor mutational heterogeneity varies by primary tumor sub-siteOncotarget20167271859810.18632/oncotarget.8448Open DOISearch in Google Scholar
Lyford-Pike S, Peng S, Young GD, Taube JM, Westra WH, Akpeng B, et al. Evidence for a role of the PD-1: PD-L1 pathway in immune resistance of human papillomavirus -associated head and neck squamous cell carcinoma. Cancer Res 2013; 73: 1733-41. doi: 10.1158/0008-5472.CAN-12-2384.Lyford-PikeSPengSYoungGDTaubeJMWestraWHAkpengBet alEvidence for a role of the PD-1: PD-L1 pathway in immune resistance of human papillomavirus -associated head and neck squamous cell carcinomaCancer Res20137317334110.1158/0008-5472.CAN-12-2384Open DOISearch in Google Scholar
Meyer HJ, Höhn A, Surov A. Histogram analysis of ADC in rectal cancer: associations with different histopathological findings including expression of EGFR, Hif1-alpha, VEGF, p53, PD1, and KI 67. A preliminary study. Oncotarget 2018; 9: 18510-7. doi: 10.18632/oncotarget.24905MeyerHJHöhnASurovAHistogram analysis of ADC in rectal cancer: associations with different histopathological findings including expression of EGFR, Hif1-alpha, VEGF, p53, PD1, and KI 67A preliminary study. Oncotarget2018918510710.18632/oncotarget.24905Open DOISearch in Google Scholar
